FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 17, 2004
Tableof Contents
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2003D-0380 Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
2004D-0361 Guidance for Industry; Prior Notice of Imported Food Contingency Plan for System Outages
2004N-0330 Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
2004N-0458 Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
2004P-0329 Request Public Hearings regarding the sales, distribution and use of hand-held Doppler fetoscopes
2004P-0513 to amend regulation update "Estrogens Increase The Risk of Enfometrial Cancer prescribing info of all strengths of Premarin tablets
2004S-0233 Stimulating Innovation in Medical Technologies
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 14762 Perrigo Company of South Carolina Vol #: 129
LET 14763 Perrigo Company of South Carolina Vol #: 129
LET 14764 Perrigo Company of South Carolina Vol #: 129
LET 14765 Perrigo Company of South Carolina Vol #: 129
LET 14766 Perrigo Company of South Carolina Vol #: 129
LET 14767 Perrigo Company of South Carolina Vol #: 129
LET 14768 Perrigo Company of South Carolina Vol #: 129
LET 14769 Perrigo Company of South Carolina Vol #: 129
LET 14770 Perrigo Company of South Carolina Vol #: 129
LET 14771 Wadayama-Cho Tokusanbutsu Association Vol #: 129
LET 14772 Enzymatic Therapy Vol #: 130
LET 14773 Enzymatic Therapy Vol #: 130
LET 14774 McLind Corporation Vol #: 130
LET 14775 McLind Corporation Vol #: 130
LET 14776 McLind Corporation Vol #: 130
LET 14777 McLind Corporation Vol #: 130
LET 14778 McLind Corporation Vol #: 130
LET 14779 McLind Corporation Vol #: 130
LET 14780 McLind Corporation Vol #: 130
LET 14781 McLind Corporation Vol #: 130
LET 14782 McLind Corporation Vol #: 130
LET 14783 McLind Corporation Vol #: 130
LET 14784 McLind Corporation Vol #: 130
LET 14785 McLind Corporation Vol #: 130
LET 14786 McLind Corporation Vol #: 130
LET 14787 McLind Corporation Vol #: 130
LET 14788 McLind Corporation Vol #: 130
LET 14789 McLind Corporation Vol #: 130
LET 14790 McLind Corporation Vol #: 130
LET 14791 McLind Corporation Vol #: 130
LET 14792 McLind Corporation Vol #: 130
LET 14793 McLind Corporation Vol #: 130
LET 14794 McLind Corporation Vol #: 130
LET 14795 McLind Corporation Vol #: 130
LET 14796 McLind Corporation Vol #: 130
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EXB 687 Bayer Corporation Vol #: 462
EXB 688 Bayer Corporation Vol #: 462
EXB 689 Bayer Corporation Vol #: 462
EXB 690 Bayer Corporation Vol #: 462
EXB 691 Bayer Corporation Vol #: 462
EXB 692 Bayer Corporation Vol #: 462
EXB 693 Bayer Corporation Vol #: 462
EXB 694 Bayer Corporation Vol #: 462
EXB 695 Bayer Corporation Vol #: 462
2003D-0380 Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
EC 4 Mr. michael pierce Vol #: 3
2004D-0361 Guidance for Industry; Prior Notice of Imported Food Contingency Plan for System Outages
EC 3 Mr. Robert Current Vol #: 1
2004N-0330 Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
EC 54 Mrs. Colleen Anderson Vol #: 1
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
EC 44 Mrs. Karla Helms-Eicher Vol #: 1
EC 45 private Vol #: 1
EC 46 Mrs. Judy Kirk Vol #: 1
EC 47 Mr. Alan Eames Vol #: 1
EC 48 Mrs. Lucy Cole Vol #: 1
EC 49 Mr. David Elrod Vol #: 1
EC 50 Mr. Keith Barefoot Vol #: 1
EC 51 Ms. Joan Roberts Vol #: 1
EC 52 Mr. Harry Frisch Vol #: 1
EC 53 Mrs. Jill Lumsden Vol #: 1
EC 54 Mr. James Weber Vol #: 1
EC 55 Dr. Andrew Ewens Vol #: 1
EC 56 Ms. Nancy Williamson Vol #: 1
2004N-0458 Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
EC 1 Mr. Z Anonymous Vol #: 1
2004P-0329 Request Public Hearings regarding the sales, distribution and use of hand-held Doppler fetoscopes
ELET 1 The BABYDATER Company Vol #: 1
2004P-0513 to amend regulation update "Estrogens Increase The Risk of Enfometrial Cancer prescribing info of all strengths of Premarin tablets
ACK 1 Beth Rosenshein Vol #: 1
CP 1
References
Beth Rosenshein Vol #: 1
2004S-0233 Stimulating Innovation in Medical Technologies
EC 17 Mr. Ronald Podraza Vol #: 1

Page created on November 18, 2004 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management